 |
|
|
| |
Renal Safety of Tenofovir Alafenamide in Patients at High Risk of Kidney Disease
|
| |
| |
Reported by Jules Levin
CROI 206 Feb 22-24 Boston
David Wohl1, Anders Thalme2, Robert Finlayson3, Shinichi Oka4, Thai Nguyen5, Susan Guo5, Andrew Cheng5, Moupali Das5, Marshall Fordyce5
1University of North Carolina at Chapel Hill, USA; 2Karolinska University Hospital, Stockholm, Sweden; 3Taylor Square Private Clinic, NSW, Australia; 4National Center for Global Health and Medicine Hospital, Tokyo, Japan; 5Gilead Sciences, Inc., Foster City, CA, USA
|
| |
|
|
|
|
|
